SCHUETZ, Matthias et al. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncologica, [S. l.], v. 49, n. 7, p. 941–947, 2010. DOI: 10.3109/0284186X.2010.510145. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/32691. Acesso em: 27 nov. 2024.